TIAA Trust, National Association
NVCR icon

TIAA Trust, National Association’s NovoCure NVCR Stock Holding History

TIAA Trust, National Association’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,035
Closed -$239K – 664
2024
Q4 		$239K Buy
+8,035
New +$170K ﹤0.01% 588

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

TIAA Trust, National Association's NVCR Position: Q1 2025 in Review

TIAA Trust, National Association sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 8,035 shares — an estimated $239K sold.

TIAA Trust, National Association first reported a position in NVCR in Q4 2024 and held it in 1 quarter. The position peaked at $239K in Q4 2024. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • TIAA Trust, National Association reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • TIAA Trust, National Association sold 8,035 NovoCure shares in Q1 2025, an estimated $239K.
  • TIAA Trust, National Association first reported a position in NovoCure in Q4 2024 and held it in 1 quarter.
  • TIAA Trust, National Association's NovoCure position peaked at $239K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on TIAA Trust, National Association's 13F filing for Q1 2025, filed 8 May 2025.